Philips launches Alturion ultrasound system
Analysis based on 9 articles · First reported Jul 08, 2026 · Last updated Jul 08, 2026
Live prominence charts, article sentiment distribution, and event development timeline available on the
Ergen Dashboard
Royal Philips announced the launch of the Alturion ultrasound system, an AI-powered device designed for high-volume clinical settings. The system received FDA 510(k) clearance and CE mark certification, making it available in the United States and Europe. Alturion features advanced imaging, AI-powered workflows, and a connected ecosystem compatible with existing Philips ultrasound systems. The launch aims to help healthcare providers improve efficiency and consistency in ultrasound examinations.
80
Philips launched
60
United States — Food and Drug Administration granted 510(k) clearance Philips
60
European Union granted certification Philips
stock
Philips launched the Alturion ultrasound system, expanding its product portfolio and potentially enhancing its market position in medical imaging.
Importance 100.0
Sentiment 10.0
alliance
The European Union granted CE mark certification for Alturion, enabling its sale in Europe.
Importance 40.0
Sentiment 0.0
govactor
The FDA granted 510(k) clearance for Alturion, allowing its sale in the United States.
Importance 40.0
Sentiment 0.0
per
Jie Xue, Chief Business Leader of Precision Diagnosis at Philips, announced the launch and highlighted the system's design for demanding clinical environments.
Importance 30.0
Sentiment 0.0
cnt
The United States is one of the initial markets where Alturion is available following FDA clearance.
Importance 20.0
Sentiment 0.0
cnt
Philips is headquartered in the Netherlands, and the launch was announced from Amsterdam.
Importance 10.0
Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard